BOTOX UROLOGY

Drug Allergan Inc.
Total Payments
$60,704
Transactions
37
Doctors
12
Companies
1

Payment Trends by Year

Year Amount Transactions Doctors
2017 $60,704 37 12

Payments by Nature

Nature of Payment Amount Transactions Share
Unspecified $46,984 22 77.4%
Consulting Fee $13,720 15 22.6%

Payments by Type

Research
$46,984
22 transactions
General
$13,720
15 transactions

Research Studies & Clinical Trials

Study Name Sponsor Amount Doctors
A Phase 2, Multi-center, Randomized, Double-Blind, Placebo-Controlled, Single Treatment, 2-Stage, Dose finding Study Evaluating the Efficacy and Safety of Botox Intravesical Installation in Participants with Overactive Bladder and Urinary Incontinence. Allergan Inc. $46,984 0

Top Doctors Receiving Payments for BOTOX UROLOGY

Doctor Specialty Location Total Records
Unknown Tacoma, WA $46,984 22
, MD Urology Gastonia, NC $4,000 1
, MD Urogynecology and Reconstructive Pelvic Surgery Charlotte, NC $1,900 2
, MD Urogynecology and Reconstructive Pelvic Surgery Cleveland, OH $1,400 2
, D.O Urology Sewell, NJ $1,200 1
, M.D Urology Va Beach, VA $960.00 1
, MD Urogynecology and Reconstructive Pelvic Surgery Albany, NY $960.00 1
, MD Urology Santa Monica, CA $800.00 1
, MD Urogynecology and Reconstructive Pelvic Surgery Houston, TX $800.00 1
, M.D Urology Columbus, OH $800.00 2
, M.D Urogynecology and Reconstructive Pelvic Surgery Hamlet, NC $300.00 1
, M.D Urogynecology and Reconstructive Pelvic Surgery Worcester, MA $300.00 1
, M.D Urogynecology and Reconstructive Pelvic Surgery Worcester, MA $300.00 1

About BOTOX UROLOGY

BOTOX UROLOGY is a drug associated with $60,704 in payments to 12 healthcare providers, recorded across 37 transactions in the CMS Open Payments database. The primary manufacturer is Allergan Inc..

Payment data is available from 2017 to 2017. In 2017, $60,704 was paid across 37 transactions to 12 doctors.

The most common payment nature for BOTOX UROLOGY is "Unspecified" ($46,984, 77.4% of total).

BOTOX UROLOGY is associated with 1 research study, including "A Phase 2, Multi-center, Randomized, Double-Blind, Placebo-Controlled, Single Treatment, 2-Stage, Dose finding Study Evaluating the Efficacy and Safety of Botox Intravesical Installation in Participants with Overactive Bladder and Urinary Incontinence." ($46,984).